Relevant BNF section: BNF 14.5.1
Intravenous human normal immunoglobulin (IVIG) is used as replacement therapy for patients with immunoglobulin deficiency and also for a few other licensed indications. Scientific rationale suggests that IVIG might help as treatment for certain serious infectious diseases that carry a high risk of death and for which there are limited alternative treatments. However, there is a limited worldwide supply of IVIG1 and the treatment is expensive. Here we assess the evidence on the efficacy of IVIG in certain infectious diseases.
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.